Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

777
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
777
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

582
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
582
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

804
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
804
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

334
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
334
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

598
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
598
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

446
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
446

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

UNICORN TAVR in Native Complex Congenital Aortic Stenosis at High Risk of Coronary Obstruction.

JACC. Case reports·2026
Same author

Infective Endocarditis Risk After Invasive Dental Procedures.

Mayo Clinic proceedings. Innovations, quality & outcomes·2025
Same author

[2025 ESC/EACTS Guidelines for the management of valvular heart disease].

Giornale italiano di cardiologia (2006)·2025
Same author

Dedicated Versus Conventional Devices in Patients With Pure Native Aortic Regurgitation: A Systematic Review and Meta-Analysis.

Journal of the American Heart Association·2025
Same author

Endocarditis Prophylaxis-Indications, Application and Current Controversies.

The Canadian journal of cardiology·2025
Same author

Aortic Valve Replacement in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis.

Journal of the Society for Cardiovascular Angiography & Interventions·2025
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
See all related articles

Related Experiment Video

Updated: Apr 4, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

18.1K

Infective endocarditis.

Thomas J Cahill1, Bernard D Prendergast2

  • 1Department of Cardiology, Oxford University Hospitals, Oxford, UK.

Lancet (London, England)
|September 6, 2015
PubMed
Summary
This summary is machine-generated.

Infective endocarditis is a serious heart valve infection with changing causes and older patients. Despite advances, mortality remains high, highlighting the need for better management strategies.

More Related Videos

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.4K
Isolation of Valvular Endothelial Cells
11:04

Isolation of Valvular Endothelial Cells

Published on: December 29, 2010

21.1K

Related Experiment Videos

Last Updated: Apr 4, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

18.1K
An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.4K
Isolation of Valvular Endothelial Cells
11:04

Isolation of Valvular Endothelial Cells

Published on: December 29, 2010

21.1K

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Infective endocarditis (IE) is a global disease affecting heart valves and cardiac devices.
  • Epidemiology shows increasing patient age and prevalence in those with indwelling devices.
  • Microbiology has shifted, with staphylococci now more common than streptococci.

Purpose of the Study:

  • To review current clinical practices for infective endocarditis.
  • To discuss unresolved controversies and emerging strategies for managing this disease.
  • To highlight the persistent high mortality rate of infective endocarditis.

Main Methods:

  • Review of recent literature on infective endocarditis.
  • Analysis of epidemiological and microbiological trends.
  • Discussion of diagnostic and therapeutic advancements.
  • Examination of clinical management challenges and controversies.

Main Results:

  • Average patient age has doubled, with increased incidence in patients with cardiac devices.
  • Staphylococci have replaced streptococci as the leading cause of infective endocarditis.
  • One-year mortality remains high at 30%, despite novel diagnostic and therapeutic approaches.

Conclusions:

  • Infective endocarditis presents evolving challenges in epidemiology and microbiology.
  • High mortality rates persist, underscoring the need for improved management strategies.
  • Addressing logistical barriers and controversies is crucial for better patient outcomes.